About Patrick Machado
Patrick Machado is a director at Alumis.
Form D filings also name Patrick Machado as a director at Avenzo Therapeutics.
Patrick Machado reports to the SEC as a director, officer or major shareholder of 18 public companies, including Arcus Biosciences (RCUS), Xenon Pharmaceuticals (XENE) and Adverum Biotechnologies (ADVM).
Patrick Machado first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Patrick Machado in the role, so the role may have started earlier or lasted longer.
AI
Arcus Biosciences, Inc.
Director
2019 – 2026 · Public company (RCUS)
XI
Xenon Pharmaceuticals Inc.
Director
2020 – 2026 · Public company (XENE)
AI
Adverum Biotechnologies, Inc.
Director
2017 – 2025 · Public company (ADVM)
AI
Acelyrin, Inc.
Director
2023 – 2025 · Public company (SLRN)
TC
Turnstone Biologics Corp.
Director
2023 · Public company (TSBX)
CI
Chimerix Inc.
Director
2014 – 2023 · Public company (CMRX)
TI
Turning Point Therapeutics, Inc.
Director
2019 – 2022 · Public company (TPTX)
RL
Roivant Sciences Ltd.
Director
2021 · Public company (ROIV)
PI
Principia Biopharma Inc.
Director
2019 – 2020 · Public company (PRNB)
UL
Urovant Sciences Ltd.
10% owner
2018 – 2019 · Public company (UROV)
ML
Myovant Sciences Ltd.
10% owner
2016 – 2019 · Public company (MYOV)
SI
Sio Gene Therapies Inc.
Director and 10% owner
2016 – 2019 · Public company (SIOX)
AC
Arbutus Biopharma Corp
10% owner
2016 – 2019 · Public company (ABUS)
SI
Scynexis Inc.
Director
2015 – 2019 · Public company (SCYX)
EI
Endocyte Inc.
Director
2018 · Public company (ECYT)
RI
Rocket Pharmaceuticals, Inc.
Director
2016 – 2017 · Public company (RCKT)
MI
Medivation, Inc.
Chief Business Officer and CFO, director
2006 – 2016 · Public company (MDVN)
Key Colleagues at Startups
The people Patrick Machado works with at each company, as listed on that company's latest Form D.
Avenzo Therapeutics, Inc. · Form D, Sep 5, 2025
CG
Carl Gordon
Director
GN
Garry Nicholson
Director
JL
Judith Li
Director
PT
Paolo Tombesi
Executive officer
MH
Mohammad Hirmand
Executive officer
SG
Simeon George
Director
SL
Scott Lipman
Executive officer
AC
Athena Countouriotis
Executive officer and director
BS
Brian Sun
Executive officer
JA
Jakob Dupont, M.D., M.A.
Director
Alumis Inc. · Form D, Jul 24, 2024
SA
Srinivas Akkaraju
Director
JS
John Schroer
Executive officer
JT
James Tananbaum
Director
DR
Derrick Richardson
Executive officer
SS
Sapna Srivastava
Director
MB
Martin Babler
CEO and director
MB
Mark Bradley
Executive officer
ZY
Zhengbin Yao
Director
SK
Sara Klein
Executive officer
DG
David Goldstein
Executive officer
JD
Jorn Drappa
Executive officer
AC
Alan Colowick
Director
RH
Roy Hardiman
Executive officer